Wacker Chemie AG Company Presentation | Market Leadership, Innovation, and Sustainability

Wacker Chemie AG Company Presentation: Key TakeawaysIntroduction to Wacker ChemieJoerg Hoffmann, Head of Investor Relations at Wacker Chemie AG, presented the company’s business model, core segments, markets, and strategies. Wacker Chemie, a leader in specialty chemicals and advanced materials, reported €6.4 billion in sales and €824 million in EBITDA for 2023, employing over 16,000 people globally. The company’s innovation, sustainability, and leadership across its four business segments—Silicones, Polymers, Polysilicon, and Biosolutions—were emphasized.Wacker’s technologies enable advances in modern computing, artificial intelligence, and renewable energy. The company consistently ranks #1 or #2 globally in its segments, leveraging vertically integrated operations and global reach for competitive advantage.Business Segments OverviewSiliconesWacker’s largest segment contributes significantly to revenue, with 85% of silicone sales from high-margin specialities. Silicones are used in industries such as construction, healthcare, automotive, and renewable energy. Applications include adhesives, insulation, e-mobility components, and coatings. Wacker’s integrated production process ensures high-quality, specialized products.PolymersThis segment focuses on sustainable, water-based binders and adhesives used in paints, construction materials, and food packaging. Key innovations include dispersible polymer powders (DPP) and vinyl acetate-ethylene (VAE)-based adhesives, addressing urbanization and green building trends by replacing plastics with environmentally friendly materials.PolysiliconWacker is a global leader in high-purity polysilicon for semiconductor and solar applications. Nearly half of all computer microchips use Wacker’s polysilicon, which supports technologies like AI and renewable energy. The segment’s focus on premium-quality products strengthens its leadership in semiconductor and solar markets.BiosolutionsThe fastest-growing segment, Biosolutions delivers advanced medicines, biopharmaceuticals, and nutraceuticals. It focuses on trends like personalized medicine with innovations such as mRNA and pDNA manufacturing. Wacker’s proprietary technologies enable cost-efficient, scalable production for pharmaceutical partners.Sustainability and Integrated OperationsSustainability is core to Wacker’s strategy, with a commitment to reducing CO2 emissions by 50% by 2030. Integrated production processes and renewable energy sources, such as hydropower, enhance efficiency. Over two-thirds of Wacker’s portfolio addresses customer sustainability needs, such as water-based adhesives and CO2-neutral materials.The SustainaBalance® strategy focuses on creating products with low environmental footprints while enabling sustainable technologies. Applications include wind turbines, solar panels, and energy-efficient building solutions.Growth Drivers and Strategic VisionWacker’s strategy emphasizes value over volume, targeting €10 billion in sales by 2030, an EBITDA margin above 20%, and a ROCE of 2x the cost of capital. Growth drivers include urbanization, energy efficiency, and the shift to renewables. Innovation and customer-centricity are key priorities, supported by a global network of technical centers delivering localized solutions.▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/Company Presentation: https://seat11a.com/investor-relations-company-presentation/Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ESG Presentation: https://seat11a.com/investor-relations-esg/T&CThis publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.